Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam in partial seizures
NCT03083665Phase 3Completed
- Sponsor
- UCB
- Start
- Aug 2017
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of brivaracetam in epilepsy, sponsored by UCB. Started Aug 2017; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03083665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03083665.